Cargando…

aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure

BACKGROUND AND AIM: The long‐term outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure (HBV‐ACLF) remain not well known. This study aimed to investigate whether aMAP score can predict re-hospitalization, hepatocellular carcinoma (HCC) occurrence and long-term mortality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yunqing, Li, Zhuohong, Liao, Guichan, Xia, Muye, Xu, Xuwen, Cai, Shaohang, Peng, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759991/ https://www.ncbi.nlm.nih.gov/pubmed/35046702 http://dx.doi.org/10.2147/IJGM.S343457

Ejemplares similares

Circulating miR-122 Is a Predictor for Virological Response in CHB Patients With High Viral Load Treated With Nucleos(t)ide Analogs
por: Wu, Yin, et al.
Publicado: (2019)

Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued
por: Liao, Guichan, et al.
Publicado: (2022)

Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B
por: Liao, Guichan, et al.
Publicado: (2021)

Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog
por: Ji, Xin, et al.
Publicado: (2020)

Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify
por: Johnson, Philip J., et al.
Publicado: (2022)

Association Between Nutritional Risk Screening Score and Prognosis of Patients with Sepsis
por: Gao, Qiqing, et al.
Publicado: (2021)

The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study
por: Chen, Yaying, et al.
Publicado: (2023)

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria
por: Ohama, Hideko, et al.
Publicado: (2023)

AMAP assessment 2015: human health in the Arctic
por: Odland, Jon Øyvind, et al.
Publicado: (2016)

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy
por: Gui, Honglian, et al.
Publicado: (2021)

Loneliness as a mediation from social support leading to a decrease of health-related quality of life among PLWHIV
por: Qian, Zhe, et al.
Publicado: (2023)

aMAP is a validated pipeline for registration and segmentation of high-resolution mouse brain data
por: Niedworok, Christian J., et al.
Publicado: (2016)

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
por: Yang, Yi, et al.
Publicado: (2021)

Oncological Effects and Prognostic Value of AMAP1 in Gastric Cancer
por: Li, Jiao, et al.
Publicado: (2021)

Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Zhang, Hao, et al.
Publicado: (2023)

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study
por: Villa, Erica, et al.
Publicado: (2023)

Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis
por: Qian, Yunsong, et al.
Publicado: (2022)

A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B
por: Ou, Hongjie, et al.
Publicado: (2016)

Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs
por: Cai, Shaohang, et al.
Publicado: (2018)

Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine
por: Cai, Shaohang, et al.
Publicado: (2017)

Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis B
por: Xie, Linqing, et al.
Publicado: (2019)

Enhancing the usability and performance of structured association mapping algorithms using automation, parallelization, and visualization in the GenAMap software system
por: Curtis, Ross E, et al.
Publicado: (2012)

iAMAP-SCM: A Novel Computational Tool for Large-Scale Identification of Antimalarial Peptides Using Estimated Propensity Scores of Dipeptides
por: Charoenkwan, Phasit, et al.
Publicado: (2022)

GWAS in a Box: Statistical and Visual Analytics of Structured Associations via GenAMap
por: Xing, Eric P., et al.
Publicado: (2014)

Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX
por: Horikawa, Mei, et al.
Publicado: (2021)

The role of the Arctic Monitoring and Assessment Programme (AMAP) in reducing pollution of the Arctic and around the globe
por: Reiersen, Lars-Otto, et al.
Publicado: (2023)

Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study
por: Hu, Meixin, et al.
Publicado: (2023)

Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis
por: Xiao, Lan-Lan, et al.
Publicado: (2019)

Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure
por: Qu, Feng, et al.
Publicado: (2014)

Corrigendum to “Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”
por: Xiao, Lan-Lan, et al.
Publicado: (2021)

AMAP1 as a negative-feedback regulator of nuclear factor-κB under inflammatory conditions
por: Tien, Dat Nguyen, et al.
Publicado: (2014)

The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion and Metastasis(†)
por: Sabe, Hisataka, et al.
Publicado: (2009)

Serum HBV RNA Dynamic and Drug Withdrawal Predictor Value in Patients With Chronic HBV Infection on Long-term Nucleos(t)ide Analogue (NA) Therapy
por: Liu, Yayun, et al.
Publicado: (2020)

Protective Role of α2HS-Glycoprotein in HBV-Associated Liver Failure
por: Dai, Xia-Hong, et al.
Publicado: (2011)

Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy
por: Kinoshita, Rumiko, et al.
Publicado: (2013)

A model for predicting high BMI of people living with HIV after receiving antiretroviral therapy
por: Qian, Zhe, et al.
Publicado: (2022)

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure
por: Wu, Wei, et al.
Publicado: (2021)

Risk factors and prognostic model for HBV-related subacute liver failure
por: Xu, Juan, et al.
Publicado: (2022)

Risk Factors Associated With Quality of Life in Patients With Hepatitis B Virus Related Cirrhosis
por: Zhang, Qi, et al.
Publicado: (2022)

Effect of Artificial Liver Support Systems on Gut Microbiota in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Song, Zhiying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_181837por6d4eiqsdbjkfm3uhp